Journal Impact Factor 1.0* ; 1.93* (5 Year Impact Factor)
International Journal of Clinical Rheumatology is at the cutting edge of the most recent clinical, translational and lab based exploration to propel the treatment for a wide range of rheumatic diseases and disorders which includes themes, for example, treatment, surgery, imaging and clinical education.
The journal is committed to distribute most elevated quality studies identified with clinical determination and administration of rheumatic ailments through facilitated parts of clinical consideration and clinical examination concentrated on propelling treatment and personal satisfaction for individuals with joint pain, immune system infections, bone issue and related conditions. This journal offers an open access platform to Rheumatology community where, the authors can publish all the reliable sources of information on research findings and current developments as original articles, reviews, case studies, clinical images, short communications, commentaries, etc. and all the published materials will be accessed online all over the world without any subscription fee. The journal gives fundamental perusing to rheumatologists and additionally orthopedic specialists, pharmacologists, pathologists, radiologists, general experts and other wellbeing experts with an enthusiasm for patients with rheumatic maladies.
The journal also incorporates original papers inside the assorted fields of rheumatology, clinical experimentation as well as medicine, pathologic process, immunology, immunopathology, microbiology and different types of radiological studies.
Indexing: Scopus, Scimago, Excerpta Medica (EMBASE), CAS (Chemical Abstracts Service)
Submit your manuscripts through Editorial Manager: http://www.editorialmanager.com/openaccessjournals
Author(s): Nadil Zeiadin*, Matthew Woo, Phylicia Verreault, Dean Tripp, Mala Joneja
Background: Functional impairment in patients with RA is a product of disease-related factors and psychosocial factors. Resilience is a novel psychosocial parameter found to have protective ..
Author(s): Tyler J. Sevco, Douglas P. Landsittel, Chengli Shen, Larry W. Moreland
Background: African American (AA) rheumatoid arthritis (RA) patients have increased disease activity compared to Caucasian (CAU) RA patients. Serum chemokines, such as CXCL10, are increased ..